
Michael Foote
Articles
-
2 months ago |
onclive.com | Michael Foote
CommentaryVideoJanuary 30, 2025Author(s):Michael Foote, MD, discusses the use of EGFR inhibitors in the first vs subsequent lines of therapy for patients with metastatic colorectal cancer. “I’m using [EGFR inhibitors] more and more up front now for my patients, especially if they’re young and they're healthy, and especially if I think we need a [to achieve a] big response that enables something else, like surgery.
-
Mar 28, 2024 |
cancernetwork.com | John Strickler |Aparna Raj Parikh |Stacey Cohen |Arvind Dasari |Michael Foote
2 Commerce Drive Cranbury, NJ 08512
-
Mar 21, 2024 |
cancernetwork.com | John Strickler |Aparna Raj Parikh |Stacey Cohen |Arvind Dasari |Michael Foote
2 Commerce Drive Cranbury, NJ 08512
-
Mar 14, 2024 |
cancernetwork.com | John Strickler |Aparna Raj Parikh |Stacey Cohen |Arvind Dasari |Michael Foote
2 Commerce Drive Cranbury, NJ 08512
-
Mar 7, 2024 |
cancernetwork.com | John Strickler |Aparna Raj Parikh |Stacey Cohen |Arvind Dasari |Michael Foote
2 Commerce Drive Cranbury, NJ 08512
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →